nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—CYP1A2—Carmustine—brain cancer	0.125	0.322	CbGbCtD
Ergotamine—CYP3A4—Temozolomide—brain cancer	0.0944	0.243	CbGbCtD
Ergotamine—CYP3A4—Lomustine—brain cancer	0.0803	0.207	CbGbCtD
Ergotamine—CYP1A2—Etoposide—brain cancer	0.037	0.0953	CbGbCtD
Ergotamine—ABCB1—Etoposide—brain cancer	0.0324	0.0833	CbGbCtD
Ergotamine—HTR1D—meninx—brain cancer	0.0278	0.0696	CbGeAlD
Ergotamine—HTR1F—trigeminal nerve—brain cancer	0.0277	0.0694	CbGeAlD
Ergotamine—HTR1B—dura mater—brain cancer	0.0264	0.0661	CbGeAlD
Ergotamine—HTR1D—dura mater—brain cancer	0.0256	0.064	CbGeAlD
Ergotamine—HTR2C—choroid plexus—brain cancer	0.0215	0.0539	CbGeAlD
Ergotamine—CYP3A4—Etoposide—brain cancer	0.0194	0.0499	CbGbCtD
Ergotamine—Gangrene—Hydroxyurea—brain cancer	0.0177	0.171	CcSEcCtD
Ergotamine—Distress—Hydroxyurea—brain cancer	0.0139	0.135	CcSEcCtD
Ergotamine—HTR1B—trigeminal nerve—brain cancer	0.0114	0.0284	CbGeAlD
Ergotamine—HTR1D—trigeminal nerve—brain cancer	0.011	0.0275	CbGeAlD
Ergotamine—HTR2A—choroid plexus—brain cancer	0.0108	0.027	CbGeAlD
Ergotamine—HTR1F—ganglion—brain cancer	0.01	0.025	CbGeAlD
Ergotamine—Emotional distress—Hydroxyurea—brain cancer	0.00908	0.0879	CcSEcCtD
Ergotamine—HTR1B—cranial nerve—brain cancer	0.00809	0.0203	CbGeAlD
Ergotamine—HTR1D—cranial nerve—brain cancer	0.00783	0.0196	CbGeAlD
Ergotamine—HTR1B—telencephalic ventricle—brain cancer	0.00658	0.0165	CbGeAlD
Ergotamine—HTR1D—telencephalic ventricle—brain cancer	0.00637	0.0159	CbGeAlD
Ergotamine—HTR2C—telencephalic ventricle—brain cancer	0.00631	0.0158	CbGeAlD
Ergotamine—HTR2A—trigeminal nerve—brain cancer	0.00546	0.0137	CbGeAlD
Ergotamine—HTR2A—cerebellar cortex—brain cancer	0.00544	0.0136	CbGeAlD
Ergotamine—HTR1A—telencephalic ventricle—brain cancer	0.00531	0.0133	CbGeAlD
Ergotamine—HTR2A—vein—brain cancer	0.00494	0.0124	CbGeAlD
Ergotamine—DRD2—telencephalic ventricle—brain cancer	0.0048	0.012	CbGeAlD
Ergotamine—HTR1B—ganglion—brain cancer	0.0041	0.0103	CbGeAlD
Ergotamine—HTR1D—ganglion—brain cancer	0.00396	0.00993	CbGeAlD
Ergotamine—HTR2C—ganglion—brain cancer	0.00393	0.00983	CbGeAlD
Ergotamine—HTR2A—cranial nerve—brain cancer	0.00389	0.00974	CbGeAlD
Ergotamine—HTR1F—telencephalon—brain cancer	0.00386	0.00965	CbGeAlD
Ergotamine—HTR2A—pons—brain cancer	0.00385	0.00963	CbGeAlD
Ergotamine—HTR1E—brainstem—brain cancer	0.00376	0.00942	CbGeAlD
Ergotamine—Cyanosis—Etoposide—brain cancer	0.00341	0.033	CcSEcCtD
Ergotamine—HTR1E—telencephalon—brain cancer	0.00334	0.00836	CbGeAlD
Ergotamine—HTR1A—ganglion—brain cancer	0.0033	0.00827	CbGeAlD
Ergotamine—SLC6A2—ganglion—brain cancer	0.00328	0.0082	CbGeAlD
Ergotamine—HTR1B—blood vessel—brain cancer	0.00326	0.00815	CbGeAlD
Ergotamine—HTR2A—telencephalic ventricle—brain cancer	0.00316	0.00792	CbGeAlD
Ergotamine—HTR1D—blood vessel—brain cancer	0.00315	0.00789	CbGeAlD
Ergotamine—DRD2—ganglion—brain cancer	0.00299	0.00748	CbGeAlD
Ergotamine—Numbness—Etoposide—brain cancer	0.00291	0.0282	CcSEcCtD
Ergotamine—Sensory loss—Etoposide—brain cancer	0.00279	0.027	CcSEcCtD
Ergotamine—HTR2A—pineal body—brain cancer	0.00275	0.00687	CbGeAlD
Ergotamine—Pain—Carboplatin—brain cancer	0.00274	0.0265	CcSEcCtD
Ergotamine—HTR1A—hindbrain—brain cancer	0.00251	0.00627	CbGeAlD
Ergotamine—HTR1F—head—brain cancer	0.0024	0.00601	CbGeAlD
Ergotamine—ADRA1A—hindbrain—brain cancer	0.00231	0.00578	CbGeAlD
Ergotamine—DRD2—hindbrain—brain cancer	0.00226	0.00567	CbGeAlD
Ergotamine—HTR1F—central nervous system—brain cancer	0.00219	0.00549	CbGeAlD
Ergotamine—HTR1E—head—brain cancer	0.00208	0.00521	CbGeAlD
Ergotamine—ADRA1D—telencephalon—brain cancer	0.00205	0.00512	CbGeAlD
Ergotamine—HTR2A—ganglion—brain cancer	0.00197	0.00493	CbGeAlD
Ergotamine—HTR1E—central nervous system—brain cancer	0.0019	0.00475	CbGeAlD
Ergotamine—Hypertension—Procarbazine—brain cancer	0.00188	0.0182	CcSEcCtD
Ergotamine—Myalgia—Procarbazine—brain cancer	0.00186	0.018	CcSEcCtD
Ergotamine—Vomiting—Lomustine—brain cancer	0.00178	0.0173	CcSEcCtD
Ergotamine—HTR1B—brainstem—brain cancer	0.00178	0.00446	CbGeAlD
Ergotamine—HTR1F—brain—brain cancer	0.00174	0.00436	CbGeAlD
Ergotamine—Tachycardia—Procarbazine—brain cancer	0.00174	0.0168	CcSEcCtD
Ergotamine—HTR1D—brainstem—brain cancer	0.00172	0.00431	CbGeAlD
Ergotamine—HTR2C—brainstem—brain cancer	0.00171	0.00427	CbGeAlD
Ergotamine—HTR2A—endothelium—brain cancer	0.0017	0.00425	CbGeAlD
Ergotamine—Nausea—Lomustine—brain cancer	0.00166	0.0161	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00162	0.0157	CcSEcCtD
Ergotamine—Paraesthesia—Procarbazine—brain cancer	0.0016	0.0155	CcSEcCtD
Ergotamine—HTR1B—telencephalon—brain cancer	0.00158	0.00395	CbGeAlD
Ergotamine—HTR2A—blood vessel—brain cancer	0.00157	0.00392	CbGeAlD
Ergotamine—Hypoaesthesia—Carmustine—brain cancer	0.00156	0.0151	CcSEcCtD
Ergotamine—HTR1D—telencephalon—brain cancer	0.00153	0.00383	CbGeAlD
Ergotamine—Pain—Procarbazine—brain cancer	0.00152	0.0147	CcSEcCtD
Ergotamine—HTR2C—telencephalon—brain cancer	0.00151	0.00379	CbGeAlD
Ergotamine—HTR1E—brain—brain cancer	0.00151	0.00377	CbGeAlD
Ergotamine—Hypoaesthesia—Temozolomide—brain cancer	0.00151	0.0146	CcSEcCtD
Ergotamine—HTR2A—hindbrain—brain cancer	0.00149	0.00374	CbGeAlD
Ergotamine—HTR1A—brainstem—brain cancer	0.00144	0.0036	CbGeAlD
Ergotamine—SLC6A2—brainstem—brain cancer	0.00142	0.00357	CbGeAlD
Ergotamine—HTR2B—telencephalon—brain cancer	0.00142	0.00356	CbGeAlD
Ergotamine—ADRA1A—brainstem—brain cancer	0.00132	0.00332	CbGeAlD
Ergotamine—ADRA1B—head—brain cancer	0.0013	0.00326	CbGeAlD
Ergotamine—DRD2—brainstem—brain cancer	0.0013	0.00325	CbGeAlD
Ergotamine—ADRA1D—endocrine gland—brain cancer	0.00129	0.00323	CbGeAlD
Ergotamine—Asthenia—Procarbazine—brain cancer	0.00128	0.0124	CcSEcCtD
Ergotamine—HTR1A—telencephalon—brain cancer	0.00127	0.00319	CbGeAlD
Ergotamine—ADRA1D—head—brain cancer	0.00127	0.00319	CbGeAlD
Ergotamine—SLC6A2—telencephalon—brain cancer	0.00126	0.00316	CbGeAlD
Ergotamine—Pruritus—Procarbazine—brain cancer	0.00126	0.0122	CcSEcCtD
Ergotamine—Hypoaesthesia—Etoposide—brain cancer	0.00121	0.0117	CcSEcCtD
Ergotamine—HTR2C—medulla oblongata—brain cancer	0.00119	0.00298	CbGeAlD
Ergotamine—ADRA1B—central nervous system—brain cancer	0.00119	0.00298	CbGeAlD
Ergotamine—Vertigo—Temozolomide—brain cancer	0.00118	0.0115	CcSEcCtD
Ergotamine—Hypertension—Carmustine—brain cancer	0.00118	0.0114	CcSEcCtD
Ergotamine—Pain—Hydroxyurea—brain cancer	0.00118	0.0114	CcSEcCtD
Ergotamine—ADRA1A—telencephalon—brain cancer	0.00118	0.00294	CbGeAlD
Ergotamine—ADRA1D—central nervous system—brain cancer	0.00116	0.00291	CbGeAlD
Ergotamine—Myalgia—Carmustine—brain cancer	0.00116	0.0112	CcSEcCtD
Ergotamine—DRD2—telencephalon—brain cancer	0.00115	0.00288	CbGeAlD
Ergotamine—Hypertension—Temozolomide—brain cancer	0.00114	0.011	CcSEcCtD
Ergotamine—HTR1B—midbrain—brain cancer	0.00113	0.00284	CbGeAlD
Ergotamine—Vomiting—Procarbazine—brain cancer	0.00113	0.011	CcSEcCtD
Ergotamine—Myalgia—Temozolomide—brain cancer	0.00112	0.0109	CcSEcCtD
Ergotamine—HTR1B—spinal cord—brain cancer	0.00111	0.00277	CbGeAlD
Ergotamine—HTR1D—midbrain—brain cancer	0.0011	0.00275	CbGeAlD
Ergotamine—HTR2C—midbrain—brain cancer	0.00109	0.00272	CbGeAlD
Ergotamine—Tachycardia—Carmustine—brain cancer	0.00109	0.0105	CcSEcCtD
Ergotamine—HTR2C—spinal cord—brain cancer	0.00106	0.00266	CbGeAlD
Ergotamine—Nausea—Procarbazine—brain cancer	0.00106	0.0102	CcSEcCtD
Ergotamine—SLC6A2—gonad—brain cancer	0.00106	0.00264	CbGeAlD
Ergotamine—ABCB1—blood vessel—brain cancer	0.00103	0.00257	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00101	0.00982	CcSEcCtD
Ergotamine—Paraesthesia—Carmustine—brain cancer	0.001	0.00968	CcSEcCtD
Ergotamine—HTR1B—endocrine gland—brain cancer	0.000996	0.00249	CbGeAlD
Ergotamine—SLC6A2—medulla oblongata—brain cancer	0.000993	0.00249	CbGeAlD
Ergotamine—Asthenia—Hydroxyurea—brain cancer	0.000988	0.00957	CcSEcCtD
Ergotamine—HTR1B—head—brain cancer	0.000984	0.00246	CbGeAlD
Ergotamine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00098	0.00949	CcSEcCtD
Ergotamine—Paraesthesia—Temozolomide—brain cancer	0.000966	0.00936	CcSEcCtD
Ergotamine—HTR1D—head—brain cancer	0.000952	0.00238	CbGeAlD
Ergotamine—Pain—Carmustine—brain cancer	0.000952	0.00922	CcSEcCtD
Ergotamine—Vertigo—Etoposide—brain cancer	0.000948	0.00918	CcSEcCtD
Ergotamine—ADRA1B—brain—brain cancer	0.000944	0.00236	CbGeAlD
Ergotamine—HTR2C—head—brain cancer	0.000943	0.00236	CbGeAlD
Ergotamine—DRD2—pituitary gland—brain cancer	0.000938	0.00235	CbGeAlD
Ergotamine—ADRA1D—brain—brain cancer	0.000923	0.00231	CbGeAlD
Ergotamine—Pain—Temozolomide—brain cancer	0.00092	0.00891	CcSEcCtD
Ergotamine—HTR1A—midbrain—brain cancer	0.000916	0.00229	CbGeAlD
Ergotamine—Hypertension—Etoposide—brain cancer	0.000911	0.00882	CcSEcCtD
Ergotamine—HTR1B—central nervous system—brain cancer	0.000898	0.00225	CbGeAlD
Ergotamine—ADRA2A—telencephalon—brain cancer	0.000894	0.00224	CbGeAlD
Ergotamine—HTR1A—spinal cord—brain cancer	0.000893	0.00224	CbGeAlD
Ergotamine—HTR2B—head—brain cancer	0.000886	0.00222	CbGeAlD
Ergotamine—Vomiting—Hydroxyurea—brain cancer	0.000876	0.00848	CcSEcCtD
Ergotamine—HTR1D—central nervous system—brain cancer	0.000869	0.00218	CbGeAlD
Ergotamine—HTR2C—central nervous system—brain cancer	0.000861	0.00216	CbGeAlD
Ergotamine—HTR2A—brainstem—brain cancer	0.000856	0.00214	CbGeAlD
Ergotamine—Tachycardia—Etoposide—brain cancer	0.00084	0.00814	CcSEcCtD
Ergotamine—DRD2—midbrain—brain cancer	0.000827	0.00207	CbGeAlD
Ergotamine—Nausea—Hydroxyurea—brain cancer	0.000818	0.00792	CcSEcCtD
Ergotamine—HTR2B—central nervous system—brain cancer	0.000809	0.00202	CbGeAlD
Ergotamine—HTR1A—endocrine gland—brain cancer	0.000804	0.00201	CbGeAlD
Ergotamine—Asthenia—Carmustine—brain cancer	0.000799	0.00774	CcSEcCtD
Ergotamine—SLC6A2—endocrine gland—brain cancer	0.000797	0.002	CbGeAlD
Ergotamine—HTR1A—head—brain cancer	0.000794	0.00199	CbGeAlD
Ergotamine—SLC6A2—head—brain cancer	0.000787	0.00197	CbGeAlD
Ergotamine—Paraesthesia—Etoposide—brain cancer	0.000773	0.00749	CcSEcCtD
Ergotamine—Asthenia—Temozolomide—brain cancer	0.000772	0.00748	CcSEcCtD
Ergotamine—Pruritus—Temozolomide—brain cancer	0.000761	0.00737	CcSEcCtD
Ergotamine—HTR2A—telencephalon—brain cancer	0.00076	0.0019	CbGeAlD
Ergotamine—ADRA2A—gonad—brain cancer	0.000746	0.00187	CbGeAlD
Ergotamine—ADRA1A—endocrine gland—brain cancer	0.000741	0.00186	CbGeAlD
Ergotamine—Pain—Etoposide—brain cancer	0.000736	0.00713	CcSEcCtD
Ergotamine—ADRA1A—head—brain cancer	0.000732	0.00183	CbGeAlD
Ergotamine—ADRA2A—pituitary gland—brain cancer	0.000728	0.00182	CbGeAlD
Ergotamine—DRD2—endocrine gland—brain cancer	0.000727	0.00182	CbGeAlD
Ergotamine—HTR1A—central nervous system—brain cancer	0.000725	0.00181	CbGeAlD
Ergotamine—SLC6A2—central nervous system—brain cancer	0.000719	0.0018	CbGeAlD
Ergotamine—DRD2—head—brain cancer	0.000717	0.0018	CbGeAlD
Ergotamine—HTR1B—brain—brain cancer	0.000713	0.00178	CbGeAlD
Ergotamine—HTR1A—cerebellum—brain cancer	0.000708	0.00177	CbGeAlD
Ergotamine—Vomiting—Carmustine—brain cancer	0.000708	0.00686	CcSEcCtD
Ergotamine—ADRA2A—medulla oblongata—brain cancer	0.000702	0.00176	CbGeAlD
Ergotamine—HTR1D—brain—brain cancer	0.00069	0.00173	CbGeAlD
Ergotamine—Vomiting—Temozolomide—brain cancer	0.000684	0.00663	CcSEcCtD
Ergotamine—HTR2C—brain—brain cancer	0.000683	0.00171	CbGeAlD
Ergotamine—ADRA1A—central nervous system—brain cancer	0.000668	0.00167	CbGeAlD
Ergotamine—Nausea—Carmustine—brain cancer	0.000661	0.00641	CcSEcCtD
Ergotamine—DRD2—central nervous system—brain cancer	0.000655	0.00164	CbGeAlD
Ergotamine—ADRA1A—cerebellum—brain cancer	0.000653	0.00163	CbGeAlD
Ergotamine—HTR2B—brain—brain cancer	0.000642	0.00161	CbGeAlD
Ergotamine—ADRA2A—midbrain—brain cancer	0.000642	0.00161	CbGeAlD
Ergotamine—DRD2—cerebellum—brain cancer	0.00064	0.0016	CbGeAlD
Ergotamine—Nausea—Temozolomide—brain cancer	0.000639	0.00619	CcSEcCtD
Ergotamine—HTR2A—gonad—brain cancer	0.000634	0.00159	CbGeAlD
Ergotamine—ADRA2A—spinal cord—brain cancer	0.000626	0.00157	CbGeAlD
Ergotamine—HTR2A—pituitary gland—brain cancer	0.000619	0.00155	CbGeAlD
Ergotamine—Asthenia—Etoposide—brain cancer	0.000618	0.00598	CcSEcCtD
Ergotamine—CYP1A2—endocrine gland—brain cancer	0.000613	0.00153	CbGeAlD
Ergotamine—Pruritus—Etoposide—brain cancer	0.000609	0.0059	CcSEcCtD
Ergotamine—HTR2A—medulla oblongata—brain cancer	0.000597	0.00149	CbGeAlD
Ergotamine—HTR1A—brain—brain cancer	0.000575	0.00144	CbGeAlD
Ergotamine—SLC6A2—brain—brain cancer	0.00057	0.00143	CbGeAlD
Ergotamine—ADRA2A—endocrine gland—brain cancer	0.000564	0.00141	CbGeAlD
Ergotamine—ADRA2A—head—brain cancer	0.000556	0.00139	CbGeAlD
Ergotamine—Vomiting—Etoposide—brain cancer	0.000547	0.0053	CcSEcCtD
Ergotamine—HTR2A—midbrain—brain cancer	0.000546	0.00137	CbGeAlD
Ergotamine—HTR2A—spinal cord—brain cancer	0.000532	0.00133	CbGeAlD
Ergotamine—ADRA1A—brain—brain cancer	0.00053	0.00133	CbGeAlD
Ergotamine—DRD2—brain—brain cancer	0.00052	0.0013	CbGeAlD
Ergotamine—Nausea—Etoposide—brain cancer	0.000511	0.00495	CcSEcCtD
Ergotamine—ADRA2A—central nervous system—brain cancer	0.000508	0.00127	CbGeAlD
Ergotamine—ABCB1—telencephalon—brain cancer	0.000498	0.00125	CbGeAlD
Ergotamine—ADRA2A—cerebellum—brain cancer	0.000496	0.00124	CbGeAlD
Ergotamine—HTR2A—endocrine gland—brain cancer	0.000479	0.0012	CbGeAlD
Ergotamine—HTR2A—head—brain cancer	0.000473	0.00118	CbGeAlD
Ergotamine—CYP3A4—endocrine gland—brain cancer	0.000444	0.00111	CbGeAlD
Ergotamine—HTR2A—central nervous system—brain cancer	0.000432	0.00108	CbGeAlD
Ergotamine—HTR2A—cerebellum—brain cancer	0.000422	0.00106	CbGeAlD
Ergotamine—ABCB1—gonad—brain cancer	0.000416	0.00104	CbGeAlD
Ergotamine—ABCB1—pituitary gland—brain cancer	0.000405	0.00101	CbGeAlD
Ergotamine—ADRA2A—brain—brain cancer	0.000403	0.00101	CbGeAlD
Ergotamine—CYP3A4—central nervous system—brain cancer	0.0004	0.001	CbGeAlD
Ergotamine—ABCB1—medulla oblongata—brain cancer	0.000391	0.000979	CbGeAlD
Ergotamine—ABCB1—midbrain—brain cancer	0.000358	0.000895	CbGeAlD
Ergotamine—ABCB1—spinal cord—brain cancer	0.000349	0.000873	CbGeAlD
Ergotamine—HTR2A—brain—brain cancer	0.000343	0.000858	CbGeAlD
Ergotamine—ABCB1—endocrine gland—brain cancer	0.000314	0.000786	CbGeAlD
Ergotamine—ABCB1—head—brain cancer	0.00031	0.000776	CbGeAlD
Ergotamine—ABCB1—central nervous system—brain cancer	0.000283	0.000708	CbGeAlD
Ergotamine—ABCB1—cerebellum—brain cancer	0.000277	0.000692	CbGeAlD
Ergotamine—ABCB1—brain—brain cancer	0.000225	0.000562	CbGeAlD
Ergotamine—HTR2B—Signaling by GPCR—IL2—brain cancer	2.71e-05	0.000249	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	2.7e-05	0.000248	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	2.69e-05	0.000247	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.67e-05	0.000245	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CCND1—brain cancer	2.65e-05	0.000243	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SPP1—brain cancer	2.65e-05	0.000243	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	2.64e-05	0.000242	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—IDH1—brain cancer	2.64e-05	0.000242	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOTCH2—brain cancer	2.63e-05	0.000242	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CTNNB1—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ENO2—brain cancer	2.61e-05	0.00024	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—HES1—brain cancer	2.58e-05	0.000237	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	2.57e-05	0.000237	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IRS2—brain cancer	2.57e-05	0.000236	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL2—brain cancer	2.56e-05	0.000236	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—VEGFA—brain cancer	2.55e-05	0.000235	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VAV1—brain cancer	2.55e-05	0.000234	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TP53—brain cancer	2.54e-05	0.000234	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL2—brain cancer	2.52e-05	0.000231	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VAV1—brain cancer	2.51e-05	0.00023	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—IL2—brain cancer	2.5e-05	0.00023	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CCND1—brain cancer	2.5e-05	0.00023	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—HES1—brain cancer	2.5e-05	0.000229	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—HES1—brain cancer	2.48e-05	0.000228	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CTNNB1—brain cancer	2.47e-05	0.000227	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—APC—brain cancer	2.47e-05	0.000227	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PIK3CG—brain cancer	2.47e-05	0.000227	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	2.46e-05	0.000226	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VAV1—brain cancer	2.45e-05	0.000225	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	2.45e-05	0.000225	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—APC—brain cancer	2.42e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PIK3CG—brain cancer	2.42e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—IL2—brain cancer	2.42e-05	0.000222	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—IL2—brain cancer	2.4e-05	0.000221	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IRS2—brain cancer	2.39e-05	0.00022	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	2.39e-05	0.00022	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SPP1—brain cancer	2.39e-05	0.000219	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—HES1—brain cancer	2.38e-05	0.000218	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	2.38e-05	0.000218	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BSG—brain cancer	2.37e-05	0.000217	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	2.36e-05	0.000217	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—VEGFA—brain cancer	2.31e-05	0.000212	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SPP1—brain cancer	2.31e-05	0.000212	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	2.3e-05	0.000211	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SPP1—brain cancer	2.29e-05	0.000211	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—STAT3—brain cancer	2.29e-05	0.00021	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VAV1—brain cancer	2.28e-05	0.000209	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL2—brain cancer	2.27e-05	0.000209	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—APC—brain cancer	2.27e-05	0.000209	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	2.27e-05	0.000209	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	2.26e-05	0.000208	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—EGFR—brain cancer	2.25e-05	0.000207	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—EGFR—brain cancer	2.2e-05	0.000202	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SPP1—brain cancer	2.2e-05	0.000202	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL2—brain cancer	2.19e-05	0.000202	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—HES1—brain cancer	2.19e-05	0.000201	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL2—brain cancer	2.18e-05	0.000201	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—VEGFA—brain cancer	2.18e-05	0.0002	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IRS2—brain cancer	2.16e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—STAT3—brain cancer	2.16e-05	0.000198	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—HES1—brain cancer	2.16e-05	0.000198	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.15e-05	0.000197	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—MYC—brain cancer	2.13e-05	0.000195	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL2—brain cancer	2.12e-05	0.000195	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—APC—brain cancer	2.11e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	2.11e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—HES1—brain cancer	2.11e-05	0.000194	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL2—brain cancer	2.09e-05	0.000192	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL2—brain cancer	2.09e-05	0.000192	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PDGFRA—brain cancer	2.09e-05	0.000192	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IRS2—brain cancer	2.09e-05	0.000192	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ENO2—brain cancer	2.08e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—EGFR—brain cancer	2.08e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IRS2—brain cancer	2.08e-05	0.000191	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—EGFR—brain cancer	2.07e-05	0.00019	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	2.05e-05	0.000189	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	2.04e-05	0.000188	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—IDH1—brain cancer	2.03e-05	0.000187	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SPP1—brain cancer	2.03e-05	0.000186	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	2.01e-05	0.000185	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—MYC—brain cancer	2e-05	0.000184	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SPP1—brain cancer	1.99e-05	0.000183	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IRS2—brain cancer	1.99e-05	0.000182	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—HES1—brain cancer	1.96e-05	0.00018	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—EGFR—brain cancer	1.96e-05	0.00018	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.95e-05	0.000179	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—brain cancer	1.93e-05	0.000177	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—RELA—brain cancer	1.93e-05	0.000177	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2—brain cancer	1.93e-05	0.000177	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	1.93e-05	0.000177	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.92e-05	0.000176	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.91e-05	0.000175	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—APC—brain cancer	1.91e-05	0.000175	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.9e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2—brain cancer	1.9e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—RELA—brain cancer	1.89e-05	0.000174	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.88e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.87e-05	0.000172	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2—brain cancer	1.86e-05	0.000171	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.84e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—APC—brain cancer	1.84e-05	0.000169	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—APC—brain cancer	1.83e-05	0.000168	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.83e-05	0.000168	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IRS2—brain cancer	1.83e-05	0.000168	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.81e-05	0.000167	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IRS2—brain cancer	1.8e-05	0.000166	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—RELA—brain cancer	1.78e-05	0.000163	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IRS2—brain cancer	1.76e-05	0.000162	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.76e-05	0.000162	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	1.75e-05	0.000161	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—APC—brain cancer	1.75e-05	0.000161	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—brain cancer	1.75e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.74e-05	0.00016	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2—brain cancer	1.74e-05	0.00016	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PIK3CG—brain cancer	1.73e-05	0.000159	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.72e-05	0.000158	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2—brain cancer	1.7e-05	0.000156	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCND1—brain cancer	1.69e-05	0.000156	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.68e-05	0.000154	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.68e-05	0.000154	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.67e-05	0.000153	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCND1—brain cancer	1.66e-05	0.000152	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—RELA—brain cancer	1.65e-05	0.000152	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—brain cancer	1.65e-05	0.000151	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.64e-05	0.000151	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	1.64e-05	0.000151	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.64e-05	0.000151	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—APC—brain cancer	1.62e-05	0.000149	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.62e-05	0.000149	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO2—brain cancer	1.61e-05	0.000148	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2—brain cancer	1.6e-05	0.000147	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	1.6e-05	0.000147	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.59e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—APC—brain cancer	1.59e-05	0.000146	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCND1—brain cancer	1.56e-05	0.000143	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—APC—brain cancer	1.56e-05	0.000143	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	1.56e-05	0.000143	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.54e-05	0.000142	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—RELA—brain cancer	1.49e-05	0.000137	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2—brain cancer	1.49e-05	0.000137	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.48e-05	0.000136	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.48e-05	0.000136	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—EGFR—brain cancer	1.47e-05	0.000135	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—STAT3—brain cancer	1.46e-05	0.000134	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCND1—brain cancer	1.45e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.45e-05	0.000133	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—APC—brain cancer	1.45e-05	0.000133	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.45e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.45e-05	0.000133	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—RELA—brain cancer	1.44e-05	0.000132	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	1.44e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—STAT3—brain cancer	1.43e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—RELA—brain cancer	1.43e-05	0.000132	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.43e-05	0.000131	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.42e-05	0.000131	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	1.42e-05	0.00013	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—RELA—brain cancer	1.37e-05	0.000126	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.36e-05	0.000125	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MYC—brain cancer	1.36e-05	0.000125	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.36e-05	0.000125	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—STAT3—brain cancer	1.35e-05	0.000124	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2—brain cancer	1.34e-05	0.000123	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MYC—brain cancer	1.33e-05	0.000122	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—EGFR—brain cancer	1.33e-05	0.000122	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.32e-05	0.000121	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCND1—brain cancer	1.31e-05	0.00012	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—EGFR—brain cancer	1.3e-05	0.00012	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	1.3e-05	0.000119	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2—brain cancer	1.3e-05	0.000119	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2—brain cancer	1.29e-05	0.000118	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.26e-05	0.000116	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—RELA—brain cancer	1.26e-05	0.000116	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCND1—brain cancer	1.26e-05	0.000116	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCND1—brain cancer	1.26e-05	0.000115	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.26e-05	0.000115	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MYC—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.25e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—RELA—brain cancer	1.24e-05	0.000114	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.24e-05	0.000114	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2—brain cancer	1.23e-05	0.000113	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—EGFR—brain cancer	1.22e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—RELA—brain cancer	1.22e-05	0.000112	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.21e-05	0.000111	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.2e-05	0.000111	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PIK3CG—brain cancer	1.2e-05	0.00011	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.19e-05	0.000109	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MYC—brain cancer	1.16e-05	0.000107	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.14e-05	0.000105	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2—brain cancer	1.14e-05	0.000105	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.14e-05	0.000105	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—RELA—brain cancer	1.13e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.13e-05	0.000104	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.12e-05	0.000103	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2—brain cancer	1.12e-05	0.000103	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—brain cancer	1.12e-05	0.000103	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCND1—brain cancer	1.11e-05	0.000102	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.1e-05	0.000101	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.1e-05	0.000101	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2—brain cancer	1.1e-05	0.000101	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.1e-05	0.000101	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—brain cancer	1.09e-05	0.0001	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCND1—brain cancer	1.09e-05	0.0001	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—STAT3—brain cancer	1.09e-05	0.0001	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—STAT3—brain cancer	1.09e-05	9.97e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	9.93e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.07e-05	9.82e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.06e-05	9.73e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MYC—brain cancer	1.05e-05	9.65e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.05e-05	9.64e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.04e-05	9.54e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.03e-05	9.44e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—brain cancer	1.03e-05	9.43e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2—brain cancer	1.02e-05	9.36e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MYC—brain cancer	1.01e-05	9.31e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MYC—brain cancer	1.01e-05	9.26e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCND1—brain cancer	9.93e-06	9.12e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—EGFR—brain cancer	9.91e-06	9.11e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—EGFR—brain cancer	9.86e-06	9.06e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	9.84e-06	9.04e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—brain cancer	9.67e-06	8.89e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MYC—brain cancer	9.65e-06	8.87e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—STAT3—brain cancer	9.58e-06	8.8e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PIK3CG—brain cancer	9.56e-06	8.78e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—brain cancer	9.55e-06	8.77e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—brain cancer	9.52e-06	8.74e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—EGFR—brain cancer	9.44e-06	8.67e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—STAT3—brain cancer	9.42e-06	8.66e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	9.32e-06	8.56e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—STAT3—brain cancer	9.23e-06	8.48e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MYC—brain cancer	8.9e-06	8.18e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MYC—brain cancer	8.76e-06	8.04e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—EGFR—brain cancer	8.71e-06	8e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	8.66e-06	7.95e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—brain cancer	8.62e-06	7.92e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MYC—brain cancer	8.57e-06	7.88e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—STAT3—brain cancer	8.57e-06	7.88e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—EGFR—brain cancer	8.57e-06	7.87e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—EGFR—brain cancer	8.39e-06	7.7e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—brain cancer	8.32e-06	7.65e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—brain cancer	8.28e-06	7.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MYC—brain cancer	7.97e-06	7.32e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—brain cancer	7.93e-06	7.28e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—EGFR—brain cancer	7.79e-06	7.16e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PIK3CG—brain cancer	7.38e-06	6.78e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—brain cancer	7.31e-06	6.71e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—brain cancer	7.19e-06	6.61e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—brain cancer	7.04e-06	6.47e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—brain cancer	6.54e-06	6.01e-05	CbGpPWpGaD
